Henry Shelford, CEO and Co-Founder of ADHD UK, was quoted in the article and provided background information.
Long-term use of ADHD medications such as methylphenidate and lisdexamfetamine may be linked to an increased risk of certain cardiovascular problems in adults, a large new study suggests — though researchers stress that the absolute risk remains low. The study found that adults prescribed ADHD drugs had a slight rise in events such as heart attacks and strokes compared with those who were not medicated, but experts caution that untreated ADHD itself also carries serious health risks and that results do not prove direct causation.
Henry Shelford, CEO of ADHD UK, responded to the findings by emphasising the importance of balanced interpretation and clinical oversight, noting that while medication can be lifesaving for many patients, it’s essential that individuals and clinicians understand potential risks and weigh them carefully as part of comprehensive, evidence-based care.
You can read the full article here: https://uk.news.yahoo.com/long-term-adhd-drugs-could-160000113.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACsssb8b7qUCzwwC7dJ1u_Q4BRk7m-X6_KLD8Th_A6yavtaMGoj_GoJxKyR-jBx7oD_Nje8AWwdbQRFziBowbIwSpAczIQUZbzThd6Dp4KORdI8d4CaOw-3MPr9LrvWB8_uT7sqc18rTD1WoTd_HYBrhRUhR9CDOOsogrqZhnuGW
